Adequacy of hormone replacement therapy for osteoporosis prevention assessed by serum oestradiol measurement, and the degree of association with menopausal symptoms

British Journal of General Practice

Volumn 47, Issue 416, 1997, Pages 161-165

  Rodgers, M ^a  

^a Bridge House Medical Centre   (United Kingdom)

Author keywords

Hormone replacement therapy; Menopause; Osteoporosis

Indexed keywords

ESTRADIOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FLUOROIMMUNOASSAY; HUMAN; MENOPAUSE; OSTEOPOROSIS; PRIMARY HEALTH CARE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SYMPTOM; TRANSDERMAL DRUG ADMINISTRATION;

ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GREAT BRITAIN; HUMANS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS;

EID: 0030965601     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hassager C, Christiansen C. Current techniques for bone mass measurement. Bailliere's Clin Obstet Gynaecol 1991; 5: 807-815.
2. Smith R. Investigation of osteoporosis. Clin Endocrinol 1996; 44: 371-374.
3. Jones KP. Estrogens and progestins: what to use and how to use it. Clin Obstet Gynecol 1992; 35: 871-883.
4. Belchetz. PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994; 330: 1062-1071.
5. Diver MJ, Nisbet JA. Warning on plasma oestradiol measurement [letter]. Lancet 1987; ii: 1097.
6. Nisbet JA, Jomain A. Discrepancies in plasma estradiol values obtained with commercial kits [letter]. Clin Chem 1987; 33: 1672.
7. Diver M. Monitoring hormone replacement therapy [letter]. Lancet 1992; 340: 1471.
8. Middle JG. The state of the art of steroid hormone assays - a UK NEQAS perspective. Commun Lab Med 1992; 3: 84-113.
9. Read GF. Oestradiol assays and hormone replacement therapy. Commun Lab Med 1992; 3: 80-83.
10. Thomas PH, Beahman JM, Fahy U, Wardle PG. Interference in the DELFIA oestradiol assay when monitoring patients receiving oestradiol valerate. Commun Lab Med 1992; 4: 70-72.